HDAC9 and cancer: Besides, silencing of HDAC9 can stop sprouting in vitro and reduce vessel growth in a zebrafish model in vivo via the repression of the miR-17-92 cluster, indicating a possible common therapeutic target for cancer vasculogenesis (Hernandez-Romero et al., 2019).